- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06232512
Multimodal Haptic Feedback for Plantar Sensory Substitution
August 5, 2026 updated by: Arun Jayaraman, PT, PhD, Shirley Ryan AbilityLab
The study will explore the use of a haptic device for sensory substitution in individuals with a movement disorder that has caused loss of plantar sensation.
The haptic device consists of two components.
The first element is a flexible insole with embedded pressure-sensing elements that transmit the spatial patterns of applied foot pressure over time.
The second element is a haptic receiver with embedded actuators that vibrate or heat up in proportion to the transmitted pressure patterns, thus substituting the patient's lost plantar sensation.
Study Overview
Detailed Description
OBJECTIVES:
- Identify a systematic, methodical approach to determine whether different users of our haptic device can perceive and use vibrational and thermal feedback in order to correct their posture in real-time.
- Evaluate whether a haptic device can be used to guide users to maintain a prescribed pattern of pressure on their feet during standing and walking.
- Investigate whether a haptic device can improve outcomes on motor evaluation tasks.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Shirley Ryan AbilityLab
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Able to ambulate 10 meters with or without assistance
- Able and willing to give written consent and comply with study procedures
Exclusion Criteria:
- Unable to give written consent or comply with study procedures
- Unable to perceive unsafe levels of heat in relevant areas
- Has a motor complete spinal cord injury
- Have transfemoral (above knee) amputation
- Any condition that would prevent the safe completion of study activities, as determined by the Principal Investigator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exploratory Arm
Individuals will complete standardized balance and walking tasks with and without sensory substitution from the haptic device system.
|
Provides sensory substitution by mapping pressure from the insole sensor onto a corresponding vibrating and heating patch to be worn where more sensation is present.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure data from the insoles
Time Frame: During the intervention
|
The primary outcome is to use the pressure-sensitive insole to ensure that we can accurately record spatial and temporal pressure data from a wide variety of healthy and non-healthy individuals.
|
During the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Arun Jayaraman, PT, PhD, Shirley Ryan AbilityLab
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 20, 2023
Primary Completion (Actual)
June 23, 2026
Study Completion (Actual)
June 23, 2026
Study Registration Dates
First Submitted
December 21, 2023
First Submitted That Met QC Criteria
January 22, 2024
First Posted (Actual)
January 30, 2024
Study Record Updates
Last Update Posted (Actual)
August 7, 2026
Last Update Submitted That Met QC Criteria
August 5, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00218277
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.